abstract |
The present invention relates to extracellular vesicle (EV)-mediated delivery of protein- based therapeutics. More specifically, the invention relates to delivery of complex polypeptide-based agents which typically bind to target proteins extracellularly, intracellularly, or in the cell membrane. |